Summary
5EA Chart
Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript
Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript
Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.14 per share a year ago.
Elanco Animal Health Incorporated (5EA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Elanco Animal Health Incorporated ever had a stock split?
Elanco Animal Health Incorporated Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Jeffrey N. Simmons CEO | XETRA Exchange | US28414H1032 ISIN |
| US Country | 9,000 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Elanco Animal Health Incorporated is an animal health company founded in 1954 with its headquarters in Greenfield, Indiana. Specializing in the innovation, development, manufacturing, and marketing of products for pets and farm animals, Elanco aims to improve the health and productivity of those animals through a comprehensive range of products. The company distributes its offerings globally, catering to third-party distributors, veterinarians, and farm animal producers, which include beef and dairy farmers, as well as those involved in pork, poultry, and aquaculture operations.
Products and Services
- Pet Health Disease Prevention: Elanco provides a variety of parasiticide and vaccine products under brands such as Seresto, Advantage, Advantix, and Advocate. These products are designed to protect pets from common pests like worms, fleas, and ticks.
- Pet Health Therapeutics: The company offers products for pain, osteoarthritis, ear infections, cardiovascular issues, and dermatology symptoms in dogs and cats. Notable brands include Galliprant and Claro, which serve to enhance the well-being of pets and treat common health conditions.
- Poultry and Aquaculture Production: For the poultry and aquaculture sectors, Elanco markets vaccines, antibiotics, parasiticides, and other essential products. They also provide nutritional health products such as enzymes, probiotics, and prebiotics to support the overall health and productivity of animals in these industries.
- Ruminant and Swine Production: Elanco supports ruminant and swine producers with a vast array of products including vaccines, antibiotics, implants, and parasiticides. Noteworthy brands such as Rumensin and Baytril play a significant role in ensuring the health and efficiency of these farm animals. These products are integral in enhancing feed efficiency, preventing disease, and maintaining the health of livestock.
